Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Yu Zhang, Jiaming Zhang, Qiuchi Xu, Yimeng Wang, Wenying Wu, Weiping Wang, Xiaoting Li & Tianhong Zhang. (2021) Simultaneous Determination of Loratadine and Its Metabolite Desloratadine in Beagle Plasma by LC-MS/MS and Application for Pharmacokinetics Study of Loratadine Tablets and Omeprazole‑Induced Drug–Drug Interaction. Drug Design, Development and Therapy 15, pages 5109-5122.
Read now
Read now
Xiu-qin Feng, Ling-ling Zhu & Quan Zhou. (2017) Opioid analgesics-related pharmacokinetic drug interactions: from the perspectives of evidence based on randomized controlled trials and clinical risk management. Journal of Pain Research 10, pages 1225-1239.
Read now
Read now
Ling-ling Zhu & Quan Zhou. (2016) The association between gastric acid inhibitors and delirium in geriatric inpatients: implications for clinical practice and research. Clinical Interventions in Aging 11, pages 797-799.
Read now
Read now
Emre Yucel, Mesut Sancar, Aylin Yucel & Betul Okuyan. (2016) Adverse drug reactions due to drug–drug interactions with proton pump inhibitors: assessment of systematic reviews with AMSTAR method. Expert Opinion on Drug Safety 15:2, pages 223-236.
Read now
Read now
Zhi-Yu Wang, Meng Chen, Ling-Ling Zhu, Lu-Shan Yu, Su Zeng, Mei-Xiang Xiang & Quan Zhou. (2015) Pharmacokinetic drug interactions with clopidogrel: updated review and risk management in combination therapy. Therapeutics and Clinical Risk Management 11, pages 449-467.
Read now
Read now
Yi-Ting Zhou, Lu-Shan Yu, Su Zeng, Yu-Wen Huang, Hui-Min Xu & Quan Zhou. (2014) Pharmacokinetic drug–drug interactions between 1,4-dihydropyridine calcium channel blockers and statins: factors determining interaction strength and relevant clinical risk management. Therapeutics and Clinical Risk Management 10, pages 17-26.
Read now
Read now
Mei-Juan Lan & Quan Zhou. (2013) Potential therapeutic hazards due to drug–drug interaction between topically and systemically coadministered medications. Therapeutics and Clinical Risk Management 9, pages 313-317.
Read now
Read now
Articles from other publishers (10)
Ling-ling Zhu & Quan Zhou. (2022) Medication Errors are Indeed Related to Source of Purchased Medication. Research in Gerontological Nursing 15:3, pages 114-115.
Crossref
Crossref
Guilherme A. Soares, Deivid W. Pires, Leonardo A. Pinto, Gustavo S. Rodrigues, André G. Prospero, Gabriel G. A. Biasotti, Gabriela N. Bittencourt, Erick G. Stoppa, Luciana A. Corá, Ricardo B. Oliveira & José R. A. Miranda. (2021) The Influence of Omeprazole on the Dissolution Processes of pH-Dependent Magnetic Tablets Assessed by Pharmacomagnetography. Pharmaceutics 13:8, pages 1274.
Crossref
Crossref
Mohamed S. AbdElhalim, Ahmed S. Kenawy, Heba H. El Demellawy, Amany A. Azouz, Sarah S. Alghanem, Torki Al-Otaibi, Osama Gheith, Mohamed Abd ElMonem, Mohammed K. Afifi & Raghda R. S. Hussein. (2020) The impact of omeprazole on mycophenolate pharmacokinetics in kidney transplant recipients. Kidney Research and Clinical Practice 39:4, pages 479-486.
Crossref
Crossref
Tomoyuki Utano, Motohiro Kato, Tomoo Osumi, Yoko Shioda, Chikako Kiyotani, Keita Terashima, Daisuke Tomizawa, Kimikazu Matsumoto & Akimasa Yamatani. (2019) Tacrolimus blood concentration increase depends on administration route when combined with voriconazole in pediatric stem cell transplant recipients. Pediatric Transplantation 24:1.
Crossref
Crossref
Beata Sienkiewicz-Oleszkiewicz, Kamila Urbańczyk, Mateusz Stachowiak, Anna Rodziewicz, Aleksander Zięba, Krzysztof Kałwak & Anna Wiela-Hojeńska. (2019) Factors Influencing the Safety and Efficiency of Antifungal Prophylaxis with Posaconazole in Children with Hematological Diseases: From Genetics to Polypharmacotherapy. Indian Journal of Hematology and Blood Transfusion 35:4, pages 699-706.
Crossref
Crossref
Jean Mozart De Lima, Amaury Lelis Dal Fabbro & André Rodrigues Funayama. (2019) USO DO OMEPRAZOL: ESTUDO DESCRITIVO DE PACIENTES IDOSOS DE UMA UNIDADE DE SAÚDE DA FAMÍLIA (USF) DE RIBEIRÃO PRETO, SP, BRASIL. Infarma - Ciências Farmacêuticas 31:1, pages 46-53.
Crossref
Crossref
Gloria Ortiz-Guerrero, Diana Amador-Muñoz, Carlos Alberto Calderón-Ospina, Daniel López-Fuentes & Mauricio Orlando Nava Mesa. (2018) Proton Pump Inhibitors and Dementia: Physiopathological Mechanisms and Clinical Consequences. Neural Plasticity 2018, pages 1-9.
Crossref
Crossref
Tatyana A. Shamliyan, Maria Middleton & Clarissa Borst. (2017) Patient-centered Outcomes with Concomitant Use of Proton Pump Inhibitors and Other Drugs. Clinical Therapeutics 39:2, pages 404-427.e36.
Crossref
Crossref
Xiu-lai Zhang, Meng Chen, Ling-ling Zhu & Quan Zhou. (2017) Therapeutic Risk and Benefits of Concomitantly Using Herbal Medicines and Conventional Medicines: From the Perspectives of Evidence Based on Randomized Controlled Trials and Clinical Risk Management. Evidence-Based Complementary and Alternative Medicine 2017, pages 1-17.
Crossref
Crossref
Mohammad Rababa, Amal Ali Al-Ghassani, Christine R. Kovach & Elaine M. Dyer. (2016) Proton Pump Inhibitors and the Prescribing Cascade. Journal of Gerontological Nursing 42:4, pages 23-31.
Crossref
Crossref